- MEI Pharma introduced a $100M non-public placement to build up Litecoin and appointed its creator Charlie Lee to the board.
- This makes MEI the primary main public firm to construct its treasury round LTC as a substitute of BTC.
- The transfer helped push LTC up 12.6%, using broader market momentum as Bitcoin topped $120K.
Litecoin’s been making waves once more—up about 12.6% since late Friday, and folk are beginning to pay nearer consideration. The spark? MEI Pharma simply pulled a wild card, asserting a $100 million non-public placement to go all-in on a Litecoin accumulation technique. Oh, they usually additionally introduced on none aside from Charlie Lee, Litecoin’s creator, to their board. That turned some heads.
MEI Pharma Bets Massive—And Bizarre
Whereas most public firms dabbling in crypto go straight for Bitcoin, MEI’s transfer is a bit off the overwhelmed path. They’re the primary big-name stock-market-listed agency to say, “Nah, let’s stack Litecoin.” It’s daring, perhaps dangerous, however undoubtedly authentic. They’re following the footsteps of giants like MicroStrategy and Trump Media—simply… with a special token.
This all got here proper earlier than Trump Media made its personal splash, asserting one other $2 billion in Bitcoin buys. Yeah, billion. So Litecoin’s sudden pump? Makes a bit extra sense now.
The Crypto Hype Cycle Is Spinning Once more
Bitcoin’s been on fireplace recently, crossing $120K and breaking information. That hype normally spills over to altcoins, and Litecoin’s no exception. Lawmakers within the U.S. are eyeing regulatory frameworks to carry crypto nearer to mainstream finance, which has added gasoline to this entire rally.
That mentioned, some of us are nonetheless skeptical. Litecoin tends to journey Bitcoin’s coattails greater than it charts its personal course. Actually? Except MEI’s technique actually pays off, Bitcoin in all probability stays the safer wager. However hey—crypto’s by no means been identified for enjoying it secure.